Dimetindene maleate
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Fenistil contains dimetindene maleate, which belongs to the group of antihistamine medicines. It inhibits the action of histamine - a substance responsible for allergic reactions. It relieves itching and irritation caused by skin rash, reduces swelling, and also relieves symptoms of allergic rhinitis, such as runny nose (cold), sneezing, nasal itching, and eye itching and tearing.
Before starting to take Fenistil, the patient should discuss it with their doctor or pharmacist, or nurse.
Elderly patients should consult their doctor before taking this medicine, as they are more susceptible to the side effects of this medicine, such as excitement and fatigue. The medicine should not be taken by elderly patients with disorientation.
Antihistamines in young children can cause excitement. The use of Fenistil in infants from 1 month to 1 year of age and in children under 6 years of age should be done on the advice of a doctor. The medicine should not be taken by children under 1 month of age.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, including those that are available without a prescription.
Like other antihistamines, Fenistil may enhance the effects of alcohol.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine. Fenistil should not be taken during pregnancy, unless the benefits to the mother outweigh the potential risk to the fetus. The medicine should only be taken under medical supervision. Fenistil should not be taken by breastfeeding women.
As with other antihistamines, Fenistil may impair psychomotor performance in some patients. Therefore, patients taking Fenistil in the form of oral drops should be cautious when driving vehicles or operating machinery.
The medicine contains 2 mg of benzoes acid per dose (40 drops), which corresponds to 1 mg/ml. Benzoes acid may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of life).
The medicine contains 200 mg of propylene glycol per dose (40 drops), which corresponds to 100 mg/ml. Before administering the medicine to a child under 4 weeks of age, the patient should consult their doctor or pharmacist, especially if the child is taking other medicines that contain propylene glycol or alcohol. The medicine contains less than 1 mmol (23 mg) of sodium per dose (40 drops), which means the medicine is considered "sodium-free".
Fenistil should always be taken exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse. If in doubt, the patient should consult their doctor, pharmacist, or nurse. The recommended dose should not be exceeded.
The medicine should not be taken for more than 7 days. If there is no improvement after 7 days or if the patient feels worse, they should contact their doctor.
Adults and children over 12 years of age
The daily dose is 3-6 mg of dimetindene, taken in 3 divided doses. It is recommended to take 20-40 drops 3 times a day.
In patients with a tendency to drowsiness, 40 drops should be taken before bedtime and 20 drops in the morning, during breakfast.
Children under 12 years of age
The recommended daily dose is 0.1 mg/kg body weight/day, taken in 3 divided doses, for example:
6 drops 3 times a day in the case of an 8-month-old infant weighing 9 kg.
8 drops 3 times a day in the case of a 2-year-old child weighing 12 kg.
The maximum daily dose should not be exceeded, which is:
1 month - 1 year 1.5 mg 30 drops
20 drops = 1 ml = 1 mg of dimetindene
Fenistil should not be exposed to high temperatures. If the infant is bottle-fed, the medicine should be added to the bottle with warm food immediately before feeding. If the infant is spoon-fed, the drops can be given undiluted, on a small teaspoon.
Elderly patients should consult their doctor before taking this medicine.
In case of taking a higher dose of Fenistil than recommended, the patient should immediately consult their doctor or pharmacist.
Symptoms of overdose are: drowsiness (mainly in adults), central nervous system stimulation (mainly in children and elderly patients), including stimulation, coordination disorders, hallucinations, tremors, convulsions, and urinary retention and fever. Hypotension, coma, and cardiovascular and respiratory collapse may occur.
In case of missing a dose, the patient should take it as soon as possible, unless there are less than 2 hours left until the next dose. In this case, the patient should take the medicine at the usual time. The patient should not take a double dose to make up for the missed dose.
Like all medicines, Fenistil can cause side effects, although not everybody gets them.
The patient should STOP taking the medicine and immediately consult their doctor if they experience any of the following symptoms, which may be signs of an allergic reaction:
These symptoms are very rare(may occur in less than 1 in 10,000 people). Other side effects that may occur are usually mild and temporary. The most common side effects occur especially at the beginning of treatment.
Very common(may occur in more than 1 in 10 people taking the medicine): fatigue.
Common(occur in less than 1 in 10 people taking the medicine): drowsiness, nervousness.
Rare(may occur in less than 1 in 1,000 people taking the medicine): stimulation, headaches, dizziness, gastrointestinal disorders, nausea, dry mouth, dry throat.
If any of the side effects get worse or if the patient experiences any side effects not listed in this leaflet, they should inform their doctor or pharmacist.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder or parallel importer.
Reporting side effects will help to gather more information on the safety of the medicine.
Store in a temperature below 25°C. Store in the original packaging to protect from light.
The medicine should be stored in a place that is out of sight and reach of children.
The medicine should not be taken after the expiry date stated on the carton and bottle. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Fenistil is a clear, colorless to light yellow-brown solution, in an orange glass bottle with a polyethylene dropper and a polypropylene child-resistant cap, placed in a cardboard box.
Available packaging:20 ml
Haleon Hungary Kft.
Csörsz utca 43
1124 Budapest
Hungary
Haleon Germany GmbH
Barthstrasse 4
80339 Munich
Germany
Allpharm Sp. z o.o. sp.k.
ul. M. Zdziechowskiego 11/4
02-659 Warsaw
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Shiraz Productions Sp. z o.o.
ul. Tymiankowa 24/28
95-054 Ksawerów
Marketing authorization number in Bulgaria, the country of export:20000512
Parallel import authorization number:55/23
[Information about the trademark]
Synoptis Industrial Sp. z o.o.
ul. Forteczna 35-37
87-100 Toruń
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.